Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 2 Interventional Results available

A Safety and Efficacy Study of BLI-1300 Ointment in Symptomatic Perianal Crohn's Disease

ClinicalTrials.gov ID: NCT01442363

Public ClinicalTrials.gov record NCT01442363. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 10:17 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Study identification

NCT ID
NCT01442363
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 2
Lead sponsor
Braintree Laboratories
Industry
Enrollment
4 participants

Conditions and interventions

Interventions

  • BLI-1300 low dose Drug
  • BLI-1300 high dose Drug
  • placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 31, 2011
Primary completion
Sep 30, 2012
Completion
Sep 30, 2012
Last update posted
Nov 12, 2023

2011 – 2012

United States locations

U.S. sites
17
U.S. states
11
U.S. cities
17
Facility City State ZIP Site status
ACRI - Phase I Anaheim California 92801
University of California - San Francisco San Francisco California 94115
Borland Groover Clinic Jacksonville Florida 32256
University of Maryland Baltimore Maryland 21201
Chevy Chase Clinical Research Chevy Chase Maryland 20815
Mayo Clinic Rochester Minnesota 55905
South Jersey Gastroenterology Marlton New Jersey 08053
Long Island Clinical Research Associates Great Neck New York 11021
New York Center for Clinical Research Lake Success New York 11042
Mount Sinai Medical Center New York New York 10029
Asheville Gastroenterology Asheville North Carolina 28801
UNC School of Medical Chapel Hill North Carolina 27599
Consultants for Clinical Research Cincinnati Ohio 45219
University Hospitals Case Medical Center Cleveland Ohio 44106
Penn State Hershey Medical Center Hershey Pennsylvania 17033
Medical University of South Carolina Charleston South Carolina 29425
Vanderbilt University Medical Center Nashville Tennessee 37212

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01442363, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 12, 2023 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01442363 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →